熊去氧膽酸全球市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計熊去氧膽酸市場將從 2025 年的 8.0215 億美元成長到 2034 年的 19.8957 億美元，2026 年至 2034 年的複合年成長率為 10.62%。

由於肝病和膽結石的盛行率不斷上升，全球熊去氧膽酸市場正穩定成長。熊去氧膽酸廣泛用於治療原發性膽汁性膽管炎和膽固醇結石。人們對肝臟健康的日益重視以及慢性疾病早期診斷的普及，都推動了市場成長。不斷擴大的藥物研發活動也進一步增強了對該產品的需求。

成長要素包括老年人口的增加以及文明病導致的肝病病例增加。製藥公司正致力於改進藥物配方並拓展適應症。新興市場醫療保健支出的增加和醫療設施可近性的提高正在加速治療方案的推廣應用。此外，學名藥的監管核准也提高了產品的供應量。

隨著新療法的探索不斷深入，未來前景一片光明。發展中地區醫療基礎設施的擴建將創造更多成長機會。預計生產商將專注於成本效益高的生產方式和建立廣泛的分銷網路。隨著全球對肝臟健康的日益關注，全球熊去氧膽酸市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球熊去氧膽酸市場：依類型分類

• 市場分析、洞察與預測
• 合成熊去氧膽酸
• 生物熊去氧膽酸

第5章 全球熊去氧膽酸市場：依應用分類

• 市場分析、洞察與預測
• 原發性膽汁性膽管炎（PBC）
• 膽結石
• 其他用途

第6章：全球熊去氧膽酸市場：依模式

• 市場分析、洞察與預測
• 內部生產
• 契約製造

第7章 全球熊去氧膽酸市場：依應用分類

• 市場分析、洞察與預測
• 人類
• 獸用

第8章 全球熊去氧膽酸市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • ICE SPA
  • Merck KGaA
  • Daewoong Bio
  • Glenmark Pharmaceuticals Ltd
  • Dipharma Francis SRL
  • IOL Chemicals And Pharmaceuticals
  • Kimia Biosciences Ltd
  • Cerata Pharmaceuticals
  • Changde Yungang Biotechnology Co. Ltd
  • Osmopharm SA
  • Tianjin NWS Biotechnology And Medicine Co. Ltd
  • Zhongshan Belling Biotechnology Co. Ltd
  • Axplora
  • Anant Pharmaceuticals Pvt. Ltd

The Ursodeoxycholic Acid Market size is expected to reach USD 1989.57 Million in 2034 from USD 802.15 Million (2025) growing at a CAGR of 10.62% during 2026-2034.

The Global Ursodeoxycholic Acid Market is growing steadily due to increasing prevalence of liver disorders and gallstone diseases. Ursodeoxycholic acid is widely used in the treatment of primary biliary cholangitis and cholesterol gallstones. Rising awareness about liver health and early diagnosis of chronic conditions are supporting market growth. Expanding pharmaceutical research and development activities are further strengthening product demand.

Key growth drivers include the growing geriatric population and increasing cases of lifestyle-related liver diseases. Pharmaceutical companies are focusing on improving drug formulations and expanding therapeutic indications. Rising healthcare expenditure and improved access to medical facilities in emerging economies are boosting treatment adoption. Additionally, favorable regulatory approvals for generic versions are enhancing product availability.

Future prospects appear positive as research continues to explore new therapeutic applications. Expanding healthcare infrastructure in developing regions will create additional growth opportunities. Manufacturers are likely to focus on cost-effective production and wider distribution networks. As awareness of liver health increases globally, the Global Ursodeoxycholic Acid Market is expected to experience steady expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Synthetic Ursodeoxycholic Acid
• Biological Ursodeoxycholic Acid

By Application

• Primary Biliary Cholangitis (PBC)
• Gall stones
• Other applications

By Mode

• In-House Manufacturing
• Contract Manufacturing

By Use

• Human
• Veterinary

COMPANIES PROFILED

• ICE SpA, Merck KGaA, Daewoong Bio, Glenmark Pharmaceuticals Ltd, Dipharma Francis Srl, IOL Chemicals and Pharmaceuticals, Kimia Biosciences Ltd, Cerata Pharmaceuticals, Changde Yungang Biotechnology Co Ltd, Osmopharm SA, Tianjin NWS Biotechnology and Medicine Co Ltd, Zhongshan Belling Biotechnology Co Ltd, Axplora, Anant Pharmaceuticals Pvt Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL URSODEOXYCHOLIC ACID MARKET: BY TYPE 2022-2034 (USD MN and Kilo Tons)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Synthetic Ursodeoxycholic Acid Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 4.3. Biological Ursodeoxycholic Acid Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 5. GLOBAL URSODEOXYCHOLIC ACID MARKET: BY APPLICATION 2022-2034 (USD MN and Kilo Tons)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Primary Biliary Cholangitis (PBC) Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 5.3. Gall stones Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 5.4. Other applications Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 6. GLOBAL URSODEOXYCHOLIC ACID MARKET: BY MODE 2022-2034 (USD MN and Kilo Tons)

• 6.1. Market Analysis, Insights and Forecast Mode
• 6.2. In-House Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 6.3. Contract Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 7. GLOBAL URSODEOXYCHOLIC ACID MARKET: BY USE 2022-2034 (USD MN and Kilo Tons)

• 7.1. Market Analysis, Insights and Forecast Use
• 7.2. Human Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 7.3. Veterinary Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 8. GLOBAL URSODEOXYCHOLIC ACID MARKET: BY REGION 2022-2034(USD MN and Kilo Tons)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.2.1 By Type
  • 8.2.2 By Application
  • 8.2.3 By Mode
  • 8.2.4 By Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.3.1 By Type
  • 8.3.2 By Application
  • 8.3.3 By Mode
  • 8.3.4 By Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.4.1 By Type
  • 8.4.2 By Application
  • 8.4.3 By Mode
  • 8.4.4 By Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.5.1 By Type
  • 8.5.2 By Application
  • 8.5.3 By Mode
  • 8.5.4 By Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.6.1 By Type
  • 8.6.2 By Application
  • 8.6.3 By Mode
  • 8.6.4 By Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL URSODEOXYCHOLIC ACID INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 ICE S.P.A
  • 10.2.2 Merck KGaA
  • 10.2.3 Daewoong Bio
  • 10.2.4 Glenmark Pharmaceuticals Ltd
  • 10.2.5 Dipharma Francis S.R.L
  • 10.2.6 IOL Chemicals And Pharmaceuticals
  • 10.2.7 Kimia Biosciences Ltd
  • 10.2.8 Cerata Pharmaceuticals
  • 10.2.9 Changde Yungang Biotechnology Co. Ltd
  • 10.2.10 Osmopharm SA
  • 10.2.11 Tianjin NWS Biotechnology And Medicine Co. Ltd
  • 10.2.12 Zhongshan Belling Biotechnology Co. Ltd
  • 10.2.13 Axplora
  • 10.2.14 Anant Pharmaceuticals Pvt. Ltd